A retrospective study of Allurion Program with Saxenda® (liraglutide)
Latest Information Update: 23 May 2023
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
Most Recent Events
- 23 May 2023 New trial record
- 18 May 2023 According to an allurion media release, results were presented at the European Congress on Obesity.
- 18 May 2023 Results presented in an allurion Media Release.